Dermapharm is a German pharmaceutical company, with €1.2bn market capitalization, that IPO early 2018.

Information for unitholders of the QUADRIGE FRANCE Smallcaps and QUADRIGE RENDEMENT France Midcaps funds
The Management Company informs unitholders of the QUADRIGE
